Study With Various Immunotherapy Treatments in Participants With Lung Cancer (NCT05676931)

🧪 Interventions in This Study

• Domvanalimab (DRUG)
• Quemliclustat (DRUG)
• Zimberelimab (DRUG)
• Docetaxel (DRUG)
• Platinum-Based Doublet (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (53 Sites)

Showing the first 25 of 53 sites.

• University of Alabama at Birmingham (UAB) — Birmingham, Alabama
• University of California San Diego (UCSD) — La Jolla, California
• Memorial Cancer Institute at Memorial Regional Hospital — Hollywood, Florida
• Hematology Oncology Associates Of The Treasure Coast — Port Saint Lucie, Florida
• Florida Cancer Specialists (Administration and Drug Shipment) — The Villages, Florida
• Northwestern Memorial Hospital — Chicago, Illinois
• Ochsner Clinic Foundation — Jefferson, Louisiana
• Henry Ford Hospital — Detroit, Michigan
• Virginia Cancer Specialists, PC — Fairfax, Virginia
• Medical Oncology Associated, PS (dba Summit Cancer Centers) — Spokane, Washington
• The Border Cancer Hospital — Albury, New South Wales
• Pindara Private Hospital — Benowa, Queensland
• Cancer Research SA Pty Ltd — Adelaide, South Australia
• Sir Charles Gairdner Hospital — Nedlands, Western Australia
• CHU Bordeaux Centre Francois Magendie Hôpital du Haut Lévèque — Bordeaux,
• Hospices Civils de Lyon Centre Hospitalier Lyon Sud — Lyon,
• Institut De Cancerologie Strasbourg Europe ICANS — Strasboug,
• Hopital FOCH — Suresnes,
• LTD High Technology Hospital Medcenter — Batumi,
• Caucasus Medical Center — Tbilisi,
• Israel Georgian Medical Research Clinic Healthycore — Tbilisi,
• JSC K. Eristavi National Center of Experimental and Clinical Surgery — Tbilisi,
• Ltd Pineo Medical Ecosystem — Tbilisi,
• Istituto Romagnolo per lo Studio dei Tumori-Dino Amadori - IRST — Meldola,
• stituto Nazionale per lo Studio e la Cura dei Tumori — Milan,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Advanced Non-Small Cell Lung Cancer

• A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) — Los Angeles, California
• Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients — Tarrytown, New York
• A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) — Tucson, Arizona
• The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer — New Haven, Connecticut
• Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Bullhead City, Arizona

Explore by condition: All Advanced Non-Small Cell Lung Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.